Application of USP apparatus 4 and in situ fiber optic analysis to microsphere release testing

Dissolution Technologies

Volumn 12, Issue 2, 2005, Pages 11-14

  Zolnik, B S ^a   Raton, J L ^b   Burgess, D J ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b Physical Testing Product Manager Sotax   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; MICROSPHERE; POLYGLACTIN; WATER OIL CREAM;

ANALYTIC METHOD; ANALYTICAL EQUIPMENT; ARTICLE; CONTROLLED DRUG RELEASE; DIFFUSION; DISSOLUTION TESTING; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; FIBER OPTICS; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; PARTICLE SIZE; SAMPLE AND SEPARATE METHOD; ULTRAVIOLET DETECTOR; USP APPARATUS 4;

EID: 84902910142     PISSN: 1521298X     EISSN: None     Source Type: Journal    
DOI: 10.14227/DT120205P11     Document Type: Article

References (9)

1. D. J. Burgess, D. J. A. Crommelin, A. J. Hussain, and M.-L. Chen. EUFEPS Workshop Report, Assuring quality and performance of sustained and controlled release parenterals. European Journal of Pharmaceutical Sciences 21: 679-690 (2004).
2. E. Allémann, R. Gurny, and J.-C. Leroux. Biodegradable Nanoparticles of Poly (lactic acid) and Poly (lactic-coglycolic acid) for Parenteral Administration. In H. A. Lieberman, M. M. Rieger, and G. S. Banker (eds), Pharmaceutical Dosage Forms: Disperse Systems, Vol. 3 (H. A. Lieberman, M. M. Rieger, and G. S. Banker, eds), Marcel Dekker, New York, 1996, pp. 163-193.
3. USP23NF18. The United States Pharmacopeia, The National Formulary, 1995.
4. X. Lu, R. Lozano, and P. Shah. In-Situ Dissolution Testing Using Different UV Fiber Optic Probes and Instruments. Dissolution Technologies 10: 6-15 (2003).
5. K. Bynum, K. Roinestad, A. Kassis, J. Pocreva, L. Gehrlein, F. Cheng, and P. Palermo. Analytical Performance of a Fiber Optic Probe Dissolution System. Dissolution Technologies 8: 13-22 (2001).
6. C. J. Toher, P. E. Nielsen, A. S. Foreman, and A. Avdeef. In Situ Fiber Optic Dissolution Monitoring of a Vitamin B12 Solid Dosage Formulation. Dissolution Technologies 10: 20-25 (2003).
7. M. Spangler, and E. Mularz. A Validated, Stability-Indicating Method for the Assay of Dexamethasone in Drug Substance and Drug Product Analyses, and the Assay of Preservatives in Drug Product. Chromatographia 54: 329-334 (2001).
8. I. Galeska, T.-K. Kim, S. Patil, U. Bhardwaj, D. Chatttopadhyay, F. Papadimitrakopoulos, and D. J. Burgess. Controlled Release of Dexamethasone from PLGA Microspheres Embedded within Polyacid-Containing PVA Hydrogels. AAPS J. (2005 in press).
9. P. L. Ritger, and N. A. Peppas. A Simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. Journal of Controlled Release 5: 23-36 (1987).